‍Bloomberg first reported that Valisure has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Defense to independently test the chemical quality of select medications. This partnership aims to generate objective, data-driven insights into drug quality—an issue increasingly recognized as a root cause of the nation’s ongoing drug shortages.

By leveraging Valisure’s independent analytical capabilities, the collaboration will help inform procurement, policy, and readiness decisions across the military health system.

View the full article via Bloomberg here.

‍Bloomberg first reported that Valisure has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Defense to independently test the chemical quality of select medications. This partnership aims to generate objective, data-driven insights into drug quality—an issue increasingly recognized as a root cause of the nation’s ongoing drug shortages.

By leveraging Valisure’s independent analytical capabilities, the collaboration will help inform procurement, policy, and readiness decisions across the military health system.

View the full article via Bloomberg here.